NCT04582318 A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 Status TERMINATED Phase PHASE1/PHASE2
NCT04578509 Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva Status COMPLETED Phase N/A
NCT04575064 An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY Status WITHDRAWN Phase PHASE2/PHASE3
NCT04555096 A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Status TERMINATED Phase PHASE2
NCT04534400 Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure Status UNKNOWN Phase N/A
NCT04533399 A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults Status COMPLETED Phase PHASE2
NCT04527354 Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04525079 To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04522830 A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 Status COMPLETED Phase PHASE2
NCT04516811 Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 Status TERMINATED Phase PHASE3
NCT04495764 Registry of Sustained Immunity to COVID-19 Among ESKD Patients Status COMPLETED Phase N/A
NCT04494776 SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study Status RECRUITING Phase N/A
NCT04492384 Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients Status COMPLETED Phase N/A
NCT04487574 A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 Status COMPLETED Phase PHASE3
NCT04471519 Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers Status COMPLETED Phase PHASE1/PHASE2